---
category: news
title: "BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence"
excerpt: "PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Deep Genomics today announced that the companies have entered into a preclinical"
publishedDateTime: 2020-11-17T12:29:00Z
originalUrl: "https://www.prnewswire.com/news-releases/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-301174203.html"
webUrl: "https://www.prnewswire.com/news-releases/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-301174203.html"
type: article
quality: 20
heat: -1
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.jpg?p=facebook"
    width: 1493
    height: 785
    isCached: true

related:
  - title: "BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence"
    excerpt: "In the collaboration, Deep Genomics will use its AI Workbench to identify and validate target mechanisms and lead candidates, and BioMarin will advance them into preclinical and clinical development."
    publishedDateTime: 2020-11-17T17:26:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    ampWebUrl: "https://markets.businessinsider.com/amp/news/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    cdnAmpWebUrl: "https://markets-businessinsider-com.cdn.ampproject.org/c/s/markets.businessinsider.com/amp/news/biomarin-and-deep-genomics-to-collaborate-on-advancing-programs-identified-using-artificial-intelligence-1029811053"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 52
  - title: "Deep Genomics hits the partnering ground running with BioMarin deal"
    excerpt: "Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer to ramp up its partnering game, it’s unveiling its first biopharma tie-up: BioMarin. The duo will use the Toronto biotech’s artificial-intelligence-based drug discovery platform to discover new drugs for rare diseases."
    publishedDateTime: 2020-11-17T12:30:00Z
    webUrl: "https://www.fiercebiotech.com/medtech/deep-genomics-hits-partnering-ground-running-biomarin-deal"
    type: article
    provider:
      name: FierceBiotech
      domain: fiercebiotech.com
    quality: 24
    images:
      - url: "https://qtxasset.com/fiercebiotech/1605581585/business-3167295_1920.jpg/business-3167295_1920.jpg?6hcgAYGOAWuchq3deRZ84GvtFYN5dzAC"
        width: 1920
        height: 1280
        isCached: true

secured: "Io+O6nWGGsDNblTKasJyIHb9aZGo21qSTt/z3pXw6L1GOkk0ZGFzSskmboLaWQauDwMFovtLWa9KGEFshAd/WScQPzAWeIn7UBgkKQ5QnAUdscMVQGer7/Tq6RTjEwLBLble855My0hthQvqTaZYPJkEZEQN0UiSb/xKuBGX6LFENrbeIJYr0AexTKzitdKC6ZIbXXzLHmGRH9taNNoVGW/h4Mm3JN2298wb/HJjGswsMM1wIHeK3OfJl05+6V4SYikdd226OujMlsCek3KLY1hNvogtM8zpjw93BjtRBBSpH5LGqMv2p7Yw21tbh9MNluzNxraMKPOup78zZ8eXxFZxSYGAeadOJ6pwe4Auc0I=;mrzpMpkNBpmAP98Q9beZbg=="
---

